Visual compatibility of argatroban with selected drugs [2]

American Journal of Health-System Pharmacy

Volumn 59, Issue 18, 2002, Pages 1784-1785

  Hartman, Christian A ^a   Baroletti, Steven A ^a   Churchill, William W ^a   Patel, Punit ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHROMBIN III; ARGATROBAN; ATROPINE; DILTIAZEM; DIPHENHYDRAMINE; DOBUTAMINE; DOPAMINE; FENTANYL CITRATE; HEPARIN; HYDROCORTISONE SODIUM SUCCINATE; METOPROLOL TARTRATE; MIDAZOLAM; MORPHINE SULFATE; NORADRENALIN; PHENYLEPHRINE; SODIUM CHLORIDE; THROMBIN; VERAPAMIL;

COLOR; DILUTION; DRUG EFFICACY; DRUG INFUSION; DRUG PROTEIN BINDING; DRUG STABILITY; FLUORESCENT LIGHTING; GAS; HUMAN; LAMINAR FLOW; LETTER; PRECIPITATION; PRIORITY JOURNAL; ROOM TEMPERATURE; ROUX Y ANASTOMOSIS; THROMBOCYTOPENIA;

EID: 0037106227     PISSN: 10792082     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajhp/59.18.1784     Document Type: Letter

References (5)

1. Novastan (brand of argatroban): A small-molecule, direct thrombin inhibitor
2. Argatroban provides effective and safe anticoagulation in patients with heparin-induced thrombocytopenia: A prospective historical controlled study
3. Anticoagulation with Novastan (argatroban) in patients with heparin-induced thrombocytopenia and heparin-induced thrombocytopenia and thrombosis syndrome
4. Compatibility of various admixtures with secondary additives at Y-injection sites of intravenous administration sets